(e) That use thereof will prevent excess fat, relieve pain orders, promote sleep, create warmth or vitality, feed the te improve the teeth or the eyes, prevent rickets, tone the blood, the user's looks, prevent goitre, promote vitality or provide zera balance;

(f) That use thereof will provide appreciable amounts of so potassium, magnesium, iron, chlorine, phosphorus, silicon, asa sulphur, iodine, fluorine or manganese;

(g) That the aforesaid preparation is a dietary supplement: (h) That the aforesaid preparation is safe to use.

The said C. A. Seroy further agreed not to publish or caus published any testimonial containing any representation contr the foregoing agreement. (1-20035, Apr. 2, 1948.)

STIPULATIONS

ST OF STIPULATIONS EFFECTED THROUGH THE COMMISSION'S DIVISION OF STIPULATIONS1

.2 Laxative Preparation-Qualities, Properties, or Results.-StipuNo. 7507 has been amended so that it now reads:

ets Products, Inc., a Tennessee corporation, with its prinffice and place of business located in Nashville, Tenn., advertiserr, and Kelly, Zahrndt & Kelly, Inc., a Missouri corporation, ts principal place of business located in St. Louis, Mo., adveragency, engaged in offering for sale and selling a laxative prepaknown as "Bi-Lets," entered into an agreement, in connection he dissemination of advertising relating to that preparation, to and desist from representing, directly or by implication, that reparation :

Will have any effect on constipation other than to afford tempoelief for that condition;

Will have any effect on symptoms such as gas on the stomach, stion, headache, tired, all-in or restless feeling, except to the that it may temporarily relieve such symptoms when they are constipation;

owing the reorganization of certain of its divisions, effective August 12, 1946, the ision (more recently Bureau) of Stipulations was charged with the handling of all considered appropriate for settlement by stipulation, including both such matters heretofore culminated in the false and misleading advertising stipulations effected the Commission's Radio and Periodical Division, as it theretofore functioned, and eretofore effected through the Trial Examiner's Division.

rst of the matters thus dealt with by the Division of Stipulations to culminate in a on was that of A. Grabczewski, trading as Larum Products, accepted September 27, hich was numbered 7506, a number arrived at through adding the 4173 stipulation handled prior thereto by the Trial Examiner's Division and the 03332 matters prior thereto by the Radio and Periodical Division, and appears in 43 F. T. C. 745. eorganization referred to, under which, among other things, the unit known as the nd Periodical Division, became a part of the Office of Legal Investigations, was to the reorganization plan drafted by the Commission in conformance with a , which was approved by the President and is described in the Commission's Report for 1946 at page 2 et seq.

lan in question, as further referred to in operation, in the Commission's Annual for 1947, was designed to expedite observance of the laws under the Commission's ion, by emphasis upon industry-wide simultaneous action and by expanding the ive phases of its work, but subject to the qualification, as there explained, that e program, with its greater emphasis on the elimination of unfair trade practices cooperative means, no matter is disposed of by voluntary agreement through trade conference or stipulation, which involves violation of the Clayton Act, combinacollective action in restraint of trade, or practices which are fraudulent or inherngerous to health.

(c) Has any effect on intestinal fermentation except to the that it may, by reason of its laxative action, remove fermented a matter from the intestinal tract;

(d) Has any effect on the liver or upon the production or 3 bile.

Bi-Lets Products, Inc., and Kelly, Zahrndt & Kelly, Inc., far's agreed not to publish or cause to be published any testimonial taining any representation contrary to the foregoing ag 1. (1-19772, Jan. 20, 1948.)

7509.3 Drug Preparations-Qualities, Properties or Results.-Se mental Stipulation No. 7509 has been amended so that it now res Southwestern Drug Corp., a Texas corporation, trading as Re row Laboratories, with its principal place of business located in I Tex., advertiser-vendor, and Ruthrauff & Ryan, Inc., a Delawar poration, with its principal office located in New York, N. Y tising agency, engaged in advertising for sale and selling, merce, drug preparations designated "Red Arrow Nose and T Drops," "Red Arrow Mineral Crystals" and "Arro-Caps," enter! an agreement, in connection with the dissemination of advertis lating to those preparations, to cease and desist from repres directly or by implication:

(a) That Red Arrow Nose and Throat Drops are beneficial treatment of colds, unless limited to such benefit as they may in temporarily relieving local nasal congestion;

(b) That Arro-Caps will correct tiredness or jittery or re conditions;

(c) That Arro-Caps afford complete or sure security from a sh of vitamins.

The two corporations further agreed not to publish or cause published any testimonial contrary to the foregoing agreement.

The two corporations further agreed that this stipulation is mental to a certain Stipulation No. 02111 accepted and appro the Federal Trade Commission on April 21, 1938, which stipe remains in full force and effect. (1-12220, Apr. 27, 1948.) 7510.5 Cosmetic Preparations-Safety and Qualities, Properties sults. Stipulation No. 7510 has been amended so that it now Overton Hygienic Mfg. Co., an Illinois corporation, with its cipal place of business located in Chicago, Ill., advertiserengaged in offering for sale and selling, in commerce, cosmetic pr tions designated "Ro-Zol Bleach," "High Brown Bleach Ointy and "Evergloss High Brown Hair Grower," entered into an

in connection with the dissemination of advertising relating se preparations, to cease and desist from representing, directly mplication:

That a cosmetic preparation now designated RO-ZOL Bleach, other preparation containing substantially the same ingredients, sessing the same properties, whether sold under that name or her name, may have no harmful effects; that it is harmless; or will remove skin blemishes;

That a cosmetic preparation now designated Evergloss or any preparation containing substantially the same ingredients or sing the same properties, whether sold under that name or any name, contains no unctuous substance; and that it will invigorate ir;

That a cosmetic preparation formerly designated High Brown Grower and now designated High Brown Hair Dressing or any preparation containing substantially the same ingredients or sing the same properties, whether sold under those names or her name will cause the hair to grow or will stimulate the growth hair.

erton Hygienic Mfg. Co. further agreed to cease and desist from the words "Hair Grower" or any similar words or phrases in esignation of the preparation "High Brown Hair Grower" or ther preparation containing substantially the same ingredients sessing substantially the same properties.

erton Hygienic Mfg. Co. further agreed not to publish or cause published any testimonial which fails to comply with the foreagreement. (1-14619, Nov. 4, 1947.)

7.6 Medicinal Preparation-Qualities, Properties or Results and Comn.-The Commission directed that Stipulation No. 7517 be ded so that it now reads:

bert I. Fleiss, an individual trading as St. Louis Medicine Co., it, Mich., advertiser-vendor, engaged in advertising for sale and g, in commerce, a medicinal preparation designated "Nu-Vita," ed into an agreement, in connection with the dissemination of tising relating to that preparation, to cease and desist from senting, directly or by implication, that the preparation : Endows one with new vitality, life, or strength;

Contains any ingredient not actually contained therein; Overcomes or corrects poor blood, high or low blood pressure, rundown conditions, pain in the back, rheumatism, nervousness, s, dizziness, dyspepsia, stomach, kidney or liver disorders due y cause;

(d) Aids in toning, or tones the nerves, digestion or blood: (e) Relieves or corrects tiredness, weakness, colds or coughs, fig or nervous indigestion.

Robert I. Fleiss further agreed not to publish or cause to be lished any testimonial containing any representation contrary to foregoing agreement. (1-19321, Apr. 6, 1948.)

7528. Medicinal Preparation-Safety, Composition and Qualities, Z erties or Results.-The Commission directed that Stipulation No. 72 be amended so that it now reads:

Paul Otto Lehmann, an individual doing business under the na name of MY-X-YM Food Enzymes Products, with his pri place of business located in Chicago, Ill., advertiser-vendor, engind in the business of offering for sale and selling in commerce, mediona preparations including the preparation designated MY-Xentered into an agreement, in connection with the disseminatio advertising relating to that product, to cease and desist from repre ing, directly or by implication:

(a) That said preparation is not habit forming, and is not har contains no artificial cathartic, contains essential health-giving ments, or is a natural food accessory;

(b) That use thereof will produce natural elimination, supply food enzymes, or supply enzymes for the needs of all organs, t or cells of the body, cause a reduction of body weight, keep b weights controlled within certain limits, or balance the daily diet:

(c) That use thereof will provide any beneficial effect when in connection with conditions known as fatigue, chronic angioneur edema, allergic eczema, allergic rhinitis, chronic allergic heads allergic vomiting, chronic urticaria, allergic edema, allergic papa eczema, chronic allergic colitis, gastric or pancreatic achylia, aci autointoxication, acne, appendicitis, colitis, colds, catarrhal dis gall bladder trouble, neuritis, underweight, obesity, piles, rheuma stomach disorders or spasmatic colon;

(d) That use thereof will provide any beneficial effect when in connection with catarrhal conditions which may manifest the selves in the sinuses, nose, ears, throat, bronchial tubes, lungs, sto liver, gall bladder, pancreas, intestine or colon;

(e) That use thereof will provide any effect on the condition k as constipation except to the extent that it may provide temperat relief therefor;

(f) That use thereof will provide any effect on symptoms such bad breath, headache or sluggishness, except to the extent that it provide temporary relief therefor when such symptoms are due constipation;

'Amendment. See 43 F. T. C. 758.